Comorbid conditions associated with Parkinson's disease: A population‐based study

The burden of comorbidity in Parkinson's disease (PD) remains unclear. All Olmsted County, Minnesota, residents with incident PD in 1976–1995 (n = 197) plus one age‐ and sex‐matched non‐PD referent subject per case were followed for all clinical diagnoses from 5 years before through 15 years after index (i.e., year of PD onset for each case and same year for the referent subject). Both members of a case–referent pair were censored at death or emigration of either member to ensure equivalent follow‐up. Cases and referent subjects were compared for summary comorbidity (Charlson index) and for the likelihood of having one or more diagnoses within each International Classification of Diseases chapter/subchapter. Before index, the groups were similar for all comparisons. After index, cases had a higher likelihood of diagnoses within the chapters “Mental Disorders” and “Diseases of the Genitourinary System,” and within the subchapters “Organic Psychotic Conditions,” “Other Psychoses,” “Neurotic/Personality/Other Nonpsychotic Disorders,” “Hereditary/Degenerative Diseases of Central Nervous System,” “Symptoms,” “Other Diseases of Digestive System,” “Other Diseases of Urinary System,” “Diseases of Veins/Lymphatics/Other Circulatory System Diseases,” “Fractures of Lower Limb,” “Other Diseases of Skin/Subcutaneous Tissue,” “Osteopathies/Chrondropathies/Acquired Musculoskeletal Deformities,” and “Pneumonia and Influenza.” The excess morbidity and mortality observed for persons with PD are consistent with recognized PD sequelae. © 2005 Movement Disorder Society

[1]  C. Roehrborn,et al.  Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. , 2000, Urology.

[2]  Daniel J Schaid,et al.  Risk tables for parkinsonism and Parkinson's disease. , 2002, Journal of clinical epidemiology.

[3]  C. Naylor,et al.  Parkinsonism in Ontario: Comorbidity associated with hospitalization in a large cohort , 2004, Movement disorders : official journal of the Movement Disorder Society.

[4]  M. Levine,et al.  Genetic Basis for Resistance to Parathyroid Hormone , 2003, Hormone Research in Paediatrics.

[5]  B. Ratcliff,et al.  Handbook of Parkinson's Disease , 1988, The Yale Journal of Biology and Medicine.

[6]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[7]  Daniel J Schaid,et al.  Survival study of Parkinson disease in Olmsted County, Minnesota. , 2003, Archives of neurology.

[8]  R. Sakakibara,et al.  Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease , 2001, Autonomic Neuroscience.

[9]  R. Mayeux,et al.  The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism , 2003, Neurology.

[10]  M. Beyer,et al.  Causes of death in a community‐based study of Parkinson's disease , 2001, Acta neurologica Scandinavica.

[11]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[12]  D. Aarsland,et al.  Risk of dementia in Parkinson’s disease: A community-based, prospective study , 2001 .

[13]  P. Hobson,et al.  The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls. , 2003, Parkinsonism & related disorders.

[14]  G. Schumock,et al.  Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[15]  H. Katzen,et al.  Cognitive Decline Affects Subject Attrition in Longitudinal Research , 2000, Journal of clinical and experimental neuropsychology.

[16]  D. Deleu Smoking, alcohol, and coffee consumption preceding Parkinson’s disease , 2001, Neurology.

[17]  M. Emre Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.

[18]  Demetrius M Maraganore,et al.  Medical services utilization and prognosis in Parkinson disease: a population-based study. , 2002, Mayo Clinic proceedings.

[19]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[20]  J. Olsson,et al.  Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9‐year follow‐up , 2003, Movement disorders : official journal of the Movement Disorder Society.

[21]  G. Meco,et al.  Mortality in a population‐based cohort of patients treated with antiparkinsonian drugs , 1998, Acta neurologica Scandinavica.

[22]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[23]  L. Melton,et al.  The threat to medical-records research. , 1997, The New England journal of medicine.

[24]  C. C. Johnson,et al.  Parkinson's disease and its comorbid disorders , 1994, Neurology.

[25]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[26]  J. Cummings,et al.  The occurrence of depression in Parkinson's disease. A community-based study. , 1996, Archives of neurology.

[27]  K. Marder,et al.  The frequency and associated risk factors for dementia in patients with Parkinson's disease. , 1995, Archives of neurology.

[28]  M. Hely,et al.  The Sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years , 1999, Journal of neurology, neurosurgery, and psychiatry.

[29]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[30]  J. Cummings,et al.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. , 1999, Archives of neurology.

[31]  M. Marmot,et al.  Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? , 1995, Journal of neurology, neurosurgery, and psychiatry.

[32]  D. Maraganore,et al.  Nonfatal Cancer Preceding Parkinson’s Disease: A Case-Control Study , 2002, Epidemiology.